Rapport Therapeutics, Inc. (RAPP) SEC Filings — 2025
11 SEC filings for Rapport Therapeutics, Inc. (RAPP) in 2025.
Filings
- RAPP's Net Loss Widens Amid Soaring R&D, Cash Reserves Boosted by Offering — 10-Q · Nov 6, 2025
- Rapport Therapeutics Enters Material Definitive Agreement — 8-K · Sep 10, 2025
- Rapport Therapeutics Files 8-K — 8-K · Sep 8, 2025
- Rapport's Q2 Losses Widen Amid R&D Surge — 10-Q · Aug 7, 2025
- Rapport Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 18, 2025
- Rapport Therapeutics, Inc. 8-K Filing — 8-K · Jun 2, 2025
- Rapport Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Rapport Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 24, 2025
- Rapport Therapeutics, Inc. 10-K Filing — 10-K · Mar 11, 2025
- Rapport Therapeutics, Inc. 8-K Filing — 8-K · Mar 3, 2025
- Roivant Sciences to Acquire Rapport Therapeutics for $180M — 8-K · Jan 10, 2025